|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1993), EMA (2012)) |
IUPAC Name ![]() |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-7-yl]indazole-3-carboxamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6230 | granisetron |
Synonyms ![]() |
| BRL 43694 |
| BRL-43694 |
| Kytril® |
| LY-278584 |
| Sancuso® |
| Sustol® |
Database Links ![]() |
|
| CAS Registry No. | 109889-09-0 (source: Scifinder) |
| DrugBank Ligand | DB00889 |
| PharmGKB Drug | PA449809 |
| PubChem CID | 5284566 |
| Search Google for chemical match using the InChIKey | MFWNKCLOYSRHCJ-AGUYFDCRSA-N |
| Search Google for chemicals with the same backbone | MFWNKCLOYSRHCJ |
| Search PubMed clinical trials | granisetron |
| Search PubMed titles | granisetron |
| Search PubMed titles/abstracts | granisetron |
| Wikipedia | Granisetron |
| Comments |
| There is some ambiguity in that the FDA label specifies 1-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide. The closest to this in PubChem is the 1S, 5R, as shown. However, the majority of the bioactivity data is linked to the enantiomer CID 3510. |